Anglo American Platinum Limited (JSE:AMS) Rating Reaffirmed
Anglo American Platinum Limited (JSE:AMS) just had their share rating of a ‘”Sector Perform”‘ issued by research analysts at RBC Capital Markets, who now has a $28000.00 target PPS on the $49.51 billion market cap company or a 64.22% upside potential. This key information was revealed to clients and investors in recent note on Wednesday, 9 December.
The stock decreased 0.14% or $24 on December 9, striking $17050. Approximately 608,824 shares of stock traded hands or 6.96% up from the average. Anglo American Platinum Ltd (JSE:AMS) has declined 30.53% since May 6, 2015 and is downtrending. It has underperformed by 29.74% the S&P500.
Anglo American Platinum Limited is a mining company. The company has a market cap of $49.51 billion. The Firm is a producer of platinum group metals . It has 16.92 P/E ratio. The Firm provides a resource-to-market service, supplying its network of global clients with a range of mined, recycled and traded products.
According to Zacks Investment Research, “American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery services, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia . The Company also offers the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the twenty first Century concept. Through its equity investment in Still River Systems, AMS also plans to complement these services with the Clinatron-two hundred fifty, proton beam radiation therapy system, which has not yet been approved by the FDA.” Get a free copy of the Zacks research report on Anglo American Platinum Ltd (AMS).